1. Extended adjuvant endocrine therapy in early breast cancer: a meta-analysis of published randomized trials

   • Ezzeldin M. Ibrahim
   • Marwan R. Al-Hajeili
   • Ahmed A. Refae

   Original Paper 15 June 2017 Article: 131

   

2. Erratum to: Advances in systemic therapy for metastatic breast cancer: future perspectives

   • S. P. Corona
   • N. Sobhani
   • D. Generali

   Erratum 14 June 2017 Article: 130

3. Neutralization of matrix metalloproteinase-9 potentially enhances oncolytic efficacy of tanapox virus for melanoma therapy

   • Tiantian Zhang
   • Yogesh R. Suryawanshi
   • Karim Essani

   Original Paper 07 June 2017 Article: 129

   

4. Aberrant gene promoter methylation of E-cadherin, p16 ^INK4a , p14 ^ARF , and MGMT in Epstein–Barr virus-associated oral squamous cell carcinomas

   • Ati Burassakarn
   • Chamsai Pientong
   • Tipaya Ekalaksananan

   Original Paper 02 June 2017 Article: 128

   

5. Downregulation of TRPM7 suppressed migration and invasion by regulating epithelial–mesenchymal transition in prostate cancer cells

   • Liang Chen
   • Rui Cao
   • Yu Xiao

   Original Paper 01 June 2017 Article: 127

   

6. Expanding the search for significant EGFR mutations in NSCLC outside of the tyrosine kinase domain with next-generation sequencing

   • Matthew K. Stein
   • Lindsay Morris
   • Mike G. Martin

   Original Paper 01 June 2017 Article: 126

7. Minimally invasive pancreatic cancer surgery: What is the current evidence?

   • Michał Pędziwiatr
   • Piotr Małczak
   • Andrzej Budzyński

   Review Article Open access 01 June 2017 Article: 125

8. Peribiliary liver metastases MR findings

   • Vincenza Granata
   • Roberta Fusco
   • Antonella Petrillo

   Original Paper 01 June 2017 Article: 124

   

9. Clinical significance of androgen secretion disorders in men with a malignancy

   • Pawel J. Wiechno
   • Grazyna M. Poniatowska
   • Tomasz Demkow

   Review Article Open access 01 June 2017 Article: 123

   

10. Epithelial-to-mesenchymal transition in tumor progression

    • Elena Prieto-García
    • C. Vanesa Díaz-García
    • M. Teresa Agulló-Ortuño

    Review Article 30 May 2017 Article: 122

    

11. Paradigm shift of therapeutic management of brain metastases in EGFR-mutant non-small cell lung cancer in the era of targeted therapy

    • Akimasa Sekine
    • Hiroaki Satoh

    Review Article 29 May 2017 Article: 121

    

12. Why do younger breast cancer patients with blood group O have favorable prognosis?

    • Kadri Altundag

    Letter to the Editor 23 May 2017 Article: 120

13. Advances in systemic therapy for metastatic breast cancer: future perspectives

    • S. P. Corona
    • N. Sobhani
    • D. Generali

    Review Article 19 May 2017 Article: 119